Ron Bentsur - 18 Mar 2024 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
18 Mar 2024
Net transactions value
+$51,450
Form type
4
Filing time
19 Mar 2024, 08:00:13 UTC
Previous filing
12 Oct 2023
Next filing
21 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $51,450 +5,000 +0.15% $10.29 3,242,484 18 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 426,759 shares of restricted stock.